Cutaneous T cell lymphoma
R Dummer, MH Vermeer, JJ Scarisbrick… - Nature Reviews …, 2021 - nature.com
Primary cutaneous T cell lymphomas (CTCLs) are a heterogeneous group of lymphomas
that present in the skin with no evidence of extracutaneous disease at the time of diagnosis …
that present in the skin with no evidence of extracutaneous disease at the time of diagnosis …
[HTML][HTML] European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome–Update …
In order to provide a common standard for the treatment of mycosis fungoides (MF) and
Sézary syndrome (SS), the European Organisation for Research and Treatment of Cancer …
Sézary syndrome (SS), the European Organisation for Research and Treatment of Cancer …
Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …
L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …
A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …
Special Issue Writing Committee is charged with reviewing, updating and categorizing …
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
YH Kim, M Bagot, L Pinter-Brown, AH Rook… - The lancet …, 2018 - thelancet.com
Background Cutaneous T-cell lymphomas are rare non-Hodgkin lymphomas with
substantial morbidity and mortality in advanced disease stages. We compared the efficacy of …
substantial morbidity and mortality in advanced disease stages. We compared the efficacy of …
Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: effect of specific prognostic …
JJ Scarisbrick, HM Prince, MH Vermeer… - Journal of Clinical …, 2015 - ascopubs.org
Purpose Advanced-stage mycosis fungoides (MF; stage IIB to IV) and Sézary syndrome (SS)
are aggressive lymphomas with a median survival of 1 to 5 years. Clinical management is …
are aggressive lymphomas with a median survival of 1 to 5 years. Clinical management is …
[HTML][HTML] Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Primary cutaneous lymphomas (PCLs) are defined as non-Hodgkin lymphomas that present
in the skin with no evidence of extracutaneous disease at the time of diagnosis. After …
in the skin with no evidence of extracutaneous disease at the time of diagnosis. After …
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and …
SI Jawed, PL Myskowski, S Horwitz… - Journal of the American …, 2014 - Elsevier
Mycosis fungoides (MF) and Sézary syndrome (SS) comprise approximately 53% of
cutaneous lymphomas. Both MF and SS may clinically and histologically mimic benign skin …
cutaneous lymphomas. Both MF and SS may clinically and histologically mimic benign skin …
Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European …
NS Agar, E Wedgeworth, S Crichton… - Journal of clinical …, 2010 - ascopubs.org
Purpose We have analyzed the outcome of mycosis fungoides (MF) and Sézary syndrome
(SS) patients using the recent International Society for Cutaneous Lymphomas …
(SS) patients using the recent International Society for Cutaneous Lymphomas …
Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes
Sézary syndrome is a rare leukemic form of cutaneous T cell lymphoma characterized by
generalized redness, scaling, itching and increased numbers of circulating atypical T …
generalized redness, scaling, itching and increased numbers of circulating atypical T …